CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 49 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $80,000 | -3.6% | 2,348 | -34.2% | 0.00% | +100.0% |
| Q1 2021 | $83,000 | -47.1% | 3,566 | -34.7% | 0.00% | -80.0% |
| Q4 2020 | $157,000 | +201.9% | 5,459 | +114.7% | 0.01% | +400.0% |
| Q3 2020 | $52,000 | -71.6% | 2,543 | -58.3% | 0.00% | -87.5% |
| Q2 2020 | $183,000 | +6000.0% | 6,096 | +5996.0% | 0.01% | – |
| Q1 2020 | $3,000 | +50.0% | 100 | -39.8% | 0.00% | – |
| Q2 2019 | $2,000 | -84.6% | 166 | -83.1% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | – | 985 | +1463.5% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 63 | -94.2% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | – | 1,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |